IndiaCOVID-19Ministry of Health and Family WelfareHealth

COVID – 19 Vaccination Update – Day 467

India’s cumulative vaccination coverage crosses 188.38 Crore. More than 17 lakh Vaccine doses administered today till 7 pm

India’s COVID-19 vaccination coverage has crossed 188.38 Crore (1,88,38,30,835today. More than 17 lakh (17,28,894) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10404962
2nd Dose 10014600
Precaution Dose 4754818
FLWs 1st Dose 18415381
2nd Dose 17536174
Precaution Dose 7492794
Age Group 12-14 years 1st Dose 27819610
  2nd Dose 4938593
Age Group 15-18 years 1st Dose 58303863
  2nd Dose 41879852
Age Group 18-44 years 1st Dose 555621347
2nd Dose 477020206
Precaution Dose 122528
Age Group 45-59 years 1st Dose 202903432
2nd Dose 187703621
Precaution Dose 439388
Over 60 years 1st Dose 126853243
2nd Dose 116938420
Precaution Dose 14668003
Cumulative 1st dose administered 1000321838
Cumulative 2nd dose administered 856031466
Precaution Dose 27477531
Total 1883830835

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 27th April, 2022 (467th Day)
HCWs 1st Dose 45
2nd Dose 585
Precaution Dose 17084
FLWs 1st Dose 123
2nd Dose 1005
Precaution Dose 43171
Age Group 12-14 years 1st Dose 254391
  2nd Dose 513313
Age Group 15-18 years 1st Dose 40152
  2nd Dose 121149
Age Group 18-44 years 1st Dose 33283
2nd Dose 392219
Precaution Dose 8992
Age Group 45-59 years 1st Dose 5024
2nd Dose 85638
Precaution Dose 34078
Over 60 years 1st Dose 3486
2nd Dose 56613
Precaution Dose 118543
Cumulative 1st dose administered 336504
Cumulative 2nd dose administered 1170522
Precaution Dose 221868
Total 1728894

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker